Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 07, 2018 Filed Dec 11, 2018 19:37 UTC |
FISHER MARYDirector
|
GrantCommon Stock | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-062108 · doc4.xml · nonDerivative · entry 1 FISHER MARY · CIK 0001272360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,319 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F2 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F2 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:42 UTC |
KOZIN MARC DDirector
|
GrantCommon Stock | 831 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-062119 · doc4.xml · nonDerivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,740 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F2 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F2 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:30 UTC |
ALDRICH RICHARDDirector
|
GrantCommon Stock | 755 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-062104 · doc4.xml · nonDerivative · entry 1 ALDRICH RICHARD · CIK 0001185039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,169 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F2 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F2 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:49 UTC |
WHITCOMB RANDALL WDirector
|
GrantStock Option (right to buy) · Derivative | 3,720 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0001209191-18-062127 · doc4.xml · derivative · entry 3 WHITCOMB RANDALL W · CIK 0001218867 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,720 Underlying: Common Stock · 3,720 shares Expires 2028-08-23 F5 · price: Received in connection with the Merger in exchange for a stock option to acquire 50,000 shares of Millendo common stock for $1.22 per share. F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:49 UTC |
WHITCOMB RANDALL WDirector
|
GrantStock Option (right to buy) · Derivative | 21,438 | Not disclosed Strike: $4.44 | Not disclosed |
DisclosureSEC source: 0001209191-18-062127 · doc4.xml · derivative · entry 2 WHITCOMB RANDALL W · CIK 0001218867 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,438 Underlying: Common Stock · 21,438 shares Expires 2026-01-27 F3 · price: Received in connection with the Merger in exchange for a stock option to acquire 288,152 shares of Millendo common stock for $0.33 per share. F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:49 UTC |
WHITCOMB RANDALL WDirector
|
GrantCommon Stock | 15,784 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-062127 · doc4.xml · nonDerivative · entry 1 WHITCOMB RANDALL W · CIK 0001218867 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,784 F1 · price: Received in exchange for 212,163 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger"). Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:38 UTC |
Gallagher Carol GiltnerDirector
|
GrantCommon Stock | 23,684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-062111 · doc4.xml · nonDerivative · entry 2 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Gallagher Revocable Trust Disclosed balance after: 23,684 F2 · price: Received in exchange for 318,335 shares of Millendo Therapeutics, Inc. common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:38 UTC |
Gallagher Carol GiltnerDirector
|
GrantCommon Stock | 8,249 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-062111 · doc4.xml · nonDerivative · entry 1 Gallagher Carol Giltner · CIK 0001329959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,249 F1 · price: Received in exchange for 110,887 shares of Millendo Therapeutics, Inc. common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:40 UTC |
Hedley Mary LynneDirector
|
GrantStock Option (right to buy) · Derivative | 18,600 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0001209191-18-062116 · doc4.xml · derivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,600 Underlying: Common Stock · 18,600 shares Expires 2028-08-23 F2 · price: Received in connection with the merger of Millendo Therapeutics, Inc. ("Millendo") into the Issuer in exchange for a stock option to acquire 250,000 shares of Millendo common stock for $1.22 per share. F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on February 24, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:48 UTC |
Mohideen PharisChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 40,919 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0001209191-18-062125 · doc4.xml · derivative · entry 4 Mohideen Pharis · CIK 0001760395 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,919 Underlying: Common Stock · 40,919 shares Expires 2028-08-23 F7 · price: Received in connection with the Merger in exchange for a stock option to acquire 550,000 shares of Millendo common stock for $1.22 per share. F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:48 UTC |
Mohideen PharisChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 37,485 | Not disclosed Strike: $4.44 | Not disclosed |
DisclosureSEC source: 0001209191-18-062125 · doc4.xml · derivative · entry 3 Mohideen Pharis · CIK 0001760395 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,485 Underlying: Common Stock · 37,485 shares Expires 2026-01-27 F5 · price: Received in connection with the Merger in exchange for a stock option to acquire 503,847 shares of Millendo common stock for $0.33 per share. F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on January 28, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:48 UTC |
Mohideen PharisChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 19,258 | Not disclosed Strike: $2.69 | Not disclosed |
DisclosureSEC source: 0001209191-18-062125 · doc4.xml · derivative · entry 2 Mohideen Pharis · CIK 0001760395 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,258 Underlying: Common Stock · 19,258 shares Expires 2024-12-04 F3 · price: Received in connection with the Merger in exchange for a stock option to acquire 258,845 shares of Millendo common stock for $0.20 per share. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:48 UTC |
Mohideen PharisChief Medical Officer
|
GrantCommon Stock | 7,440 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-062125 · doc4.xml · nonDerivative · entry 1 Mohideen Pharis · CIK 0001760395 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,440 F1 · price: Received in exchange for 100,000 shares of Millendo Therapeutics, Inc. ("Millendo") common stock in connection with merger of Millendo Therapeutics, Inc. into the Issuer (the "Merger"). Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:41 UTC |
Hindman James M.Director
|
GrantStock Option (right to buy) · Derivative | 3,720 | Not disclosed Strike: $16.40 | Not disclosed |
DisclosureSEC source: 0001209191-18-062117 · doc4.xml · derivative · entry 2 Hindman James M. · CIK 0001617615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,720 Underlying: Common Stock · 3,720 shares Expires 2028-08-23 F4 · price: Received in connection with the Merger in exchange for a stock option to acquire 50,000 shares of Millendo common stock for $1.22 per share. F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:41 UTC |
Hindman James M.Director
|
GrantStock Option (right to buy) · Derivative | 17,509 | Not disclosed Strike: $6.59 | Not disclosed |
DisclosureSEC source: 0001209191-18-062117 · doc4.xml · derivative · entry 1 Hindman James M. · CIK 0001617615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,509 Underlying: Common Stock · 17,509 shares Expires 2026-08-09 F2 · price: Received in connection with the merger of Millendo Therapeutics, Inc. ("Millendo") into the Issuer (the "Merger") in exchange for a stock option to acquire 235,341 shares of Millendo common stock for $0.49 per share. F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on June 17, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 18:03 UTC |
FISHER MARYDirector
|
GrantCommon Stock | 6,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011955 · edgar.xml · nonDerivative · entry 1 FISHER MARY · CIK 0001272360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,460 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 22:03 UTC |
KOZIN MARC DDirector
|
GrantCommon Stock | 16,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011956 · edgar.xml · nonDerivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,647 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 18:03 UTC |
ALDRICH RICHARDDirector
|
GrantCommon Stock | 14,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011954 · edgar.xml · nonDerivative · entry 1 ALDRICH RICHARD · CIK 0001185039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,220 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| July 04, 2018 Filed Jul 6, 2018 18:33 UTC |
FISHER MARYDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001179110-18-009534 · edgar.xml · derivative · entry 1 FISHER MARY · CIK 0001272360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-07-04 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018. Read SEC document |
| July 04, 2018 Filed Jul 6, 2018 22:34 UTC |
KOZIN MARC DDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001179110-18-009536 · edgar.xml · derivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-07-04 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018. Read SEC document |
| July 04, 2018 Filed Jul 6, 2018 22:32 UTC |
CAPELLO JEFFREY DDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001179110-18-009533 · edgar.xml · derivative · entry 1 CAPELLO JEFFREY D · CIK 0001224108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-07-04 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018. Read SEC document |
| July 04, 2018 Filed Jul 6, 2018 18:31 UTC |
ALDRICH RICHARDDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001179110-18-009532 · edgar.xml · derivative · entry 1 ALDRICH RICHARD · CIK 0001185039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-07-04 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018. Read SEC document |
| July 04, 2018 Filed Jul 6, 2018 18:33 UTC |
HOWE JOHN P MDDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001179110-18-009535 · edgar.xml · derivative · entry 1 HOWE JOHN P MD · CIK 0001190348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-07-04 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018. Read SEC document |
| July 04, 2018 Filed Jul 6, 2018 22:34 UTC |
Sexton JohnDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001179110-18-009537 · edgar.xml · derivative · entry 1 Sexton John · CIK 0001640938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-07-04 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 16:37 UTC |
FISHER MARYDirector
|
GrantCommon Stock | 5,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009348 · edgar.xml · nonDerivative · entry 1 FISHER MARY · CIK 0001272360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,609 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:38 UTC |
KOZIN MARC DDirector
|
GrantCommon Stock | 12,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009350 · edgar.xml · nonDerivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,633 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 16:35 UTC |
ALDRICH RICHARDDirector
|
GrantCommon Stock | 11,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009346 · edgar.xml · nonDerivative · entry 1 ALDRICH RICHARD · CIK 0001185039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,662 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| May 10, 2018 Filed Dec 12, 2018 00:43 UTC |
Kroeger Christopher A.Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 47,666 | $0.00 Strike: $13.98 | $0.00 |
DisclosureSEC source: 0001209191-18-062120 · doc4.xml · derivative · entry 1 Kroeger Christopher A. · CIK 0001658918 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,666 Underlying: Common Stock · 47,666 shares Expires 2028-05-10 F1 · derivative.exercise_price: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F1 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F2 · derivative.exercise_date: The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause). F1 · derivative.underlying_shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F1 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. Read SEC document |
| May 10, 2018 Filed Dec 12, 2018 00:46 UTC |
Lillie James WoodruffChief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,333 | $0.00 Strike: $13.98 | $0.00 |
DisclosureSEC source: 0001209191-18-062124 · doc4.xml · derivative · entry 1 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2028-05-10 F1 · derivative.exercise_price: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F1 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F2 · derivative.exercise_date: The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause). F1 · derivative.underlying_shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F1 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. Read SEC document |
| May 10, 2018 Filed Dec 12, 2018 00:39 UTC |
GILLIS JONATHANSenior Vice President, Finance
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $13.98 | $0.00 |
DisclosureSEC source: 0001209191-18-062113 · doc4.xml · derivative · entry 1 GILLIS JONATHAN · CIK 0001709954 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-05-10 F1 · derivative.exercise_price: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F1 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F2 · derivative.exercise_date: The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause). F1 · derivative.underlying_shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. F1 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018. Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 17:25 UTC |
FISHER MARYDirector
|
GrantCommon Stock | 6,165 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005302 · edgar.xml · nonDerivative · entry 1 FISHER MARY · CIK 0001272360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,099 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 21:26 UTC |
KOZIN MARC DDirector
|
GrantCommon Stock | 14,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005303 · edgar.xml · nonDerivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,753 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 17:25 UTC |
ALDRICH RICHARDDirector
|
GrantCommon Stock | 13,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-005301 · edgar.xml · nonDerivative · entry 1 ALDRICH RICHARD · CIK 0001185039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,953 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| March 06, 2018 Filed Mar 6, 2018 22:56 UTC |
Lillie James WoodruffChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 357,057 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001179110-18-003673 · edgar.xml · derivative · entry 1 Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,057 Underlying: Common Stock · 357,057 shares Expires 2028-03-05 F1 · derivative.exercise_date: The shares underlying this option shall vest as to 25% of the shares on the first anniversary of the commencement of the Reporting Person's employment (which began on January 16, 2018), with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 23:23 UTC |
GILLIS JONATHANSenior Vice President, Finance
|
GrantStock Option (right to buy) · Derivative | 128,645 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001179110-18-001912 · edgar.xml · derivative · entry 1 GILLIS JONATHAN · CIK 0001709954 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,645 Underlying: Common Stock · 128,645 shares Expires 2028-02-08 F1 · derivative.exercise_date: The option shall vest as to 25% of the shares on February 8, 2019 and the remaining shares shall vest in equal quarterly installments over 12 quarters, ending February 8, 2022. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 20:37 UTC |
FISHER MARYDirector
|
GrantCommon Stock | 3,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-000449 · edgar.xml · nonDerivative · entry 1 FISHER MARY · CIK 0001272360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,934 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| December 29, 2017 Filed Jan 4, 2018 01:42 UTC |
KOZIN MARC DDirector
|
GrantCommon Stock | 8,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-000450 · edgar.xml · nonDerivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,342 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 20:34 UTC |
ALDRICH RICHARDDirector
|
GrantCommon Stock | 7,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-000448 · edgar.xml · nonDerivative · entry 1 ALDRICH RICHARD · CIK 0001185039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,852 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $10,625 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 19:48 UTC |
FISHER MARYDirector
|
GrantCommon Stock | 3,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013054 · edgar.xml · nonDerivative · entry 1 FISHER MARY · CIK 0001272360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,363 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 23:47 UTC |
KOZIN MARC DDirector
|
GrantCommon Stock | 8,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013053 · edgar.xml · nonDerivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,994 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 19:46 UTC |
ALDRICH RICHARDDirector
|
GrantCommon Stock | 7,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013052 · edgar.xml · nonDerivative · entry 1 ALDRICH RICHARD · CIK 0001185039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,263 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:12 UTC |
FISHER MARYDirector
|
GrantCommon Stock | 3,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-010100 · edgar.xml · nonDerivative · entry 1 FISHER MARY · CIK 0001272360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,842 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 23:11 UTC |
KOZIN MARC DDirector
|
GrantCommon Stock | 6,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-010099 · edgar.xml · nonDerivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,764 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:11 UTC |
ALDRICH RICHARDDirector
|
GrantCommon Stock | 6,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-010098 · edgar.xml · nonDerivative · entry 1 ALDRICH RICHARD · CIK 0001185039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,781 F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:57 UTC |
FISHER MARYDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009557 · edgar.xml · derivative · entry 1 FISHER MARY · CIK 0001272360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-21 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017. Read SEC document |
| June 21, 2017 Filed Jun 24, 2017 00:55 UTC |
KOZIN MARC DDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009552 · edgar.xml · derivative · entry 1 KOZIN MARC D · CIK 0001241647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-21 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017. Read SEC document |
| June 21, 2017 Filed Jun 24, 2017 00:56 UTC |
CAPELLO JEFFREY DDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009555 · edgar.xml · derivative · entry 1 CAPELLO JEFFREY D · CIK 0001224108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-21 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:57 UTC |
ALDRICH RICHARDDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009556 · edgar.xml · derivative · entry 1 ALDRICH RICHARD · CIK 0001185039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-21 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:56 UTC |
HOWE JOHN P MDDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009554 · edgar.xml · derivative · entry 1 HOWE JOHN P MD · CIK 0001190348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-21 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017. Read SEC document |
| June 21, 2017 Filed Jun 24, 2017 00:56 UTC |
Sexton JohnDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001179110-17-009553 · edgar.xml · derivative · entry 1 Sexton John · CIK 0001640938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-21 F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.